Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor

NCT00095329 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

14

Enrollment

NIH

Sponsor class

Stopped Due to slow recruitment.

Conditions

Multiple Sclerosis (MS) - Relapsing-remitting

Interventions

BIOLOGICAL: sirolimus

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]